Please login to the form below

Not currently logged in


This page shows the latest NVX-CoV2373 news and features for those working in and with pharma, biotech and healthcare.

US trial data shows Novavax’s COVID-19 vaccine is 90% effective

US trial data shows Novavax’s COVID-19 vaccine is 90% effective

New data from a trial conducted in the US and Mexico has showed that Novavax’s COVID-19 vaccine NVX-CoV2373 is 90% effective at preventing COVID-19. ... PREVENT-19 confirms that NVX-CoV2373 offers a reassuring tolerability and safety profile.

Latest news

More from news
Approximately 1 fully matching, plus 15 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....